Results 21 to 30 of about 56,147 (276)
The objective was to summarize recent findings about the clinical features, diagnosis and investigation of dementia with Lewy (DLB) bodies, together with its neuropathology, neurochemistry and genetics. Dementia with Lewy bodies (DLB) is a primary, neurodegenerative dementia sharing clinical and pathological characteristics with both Parkinson's ...
McKeith IG +10 more
+9 more sources
The regulatory path for drug approval is increasingly well defined. Drugs for the treatment of Alzheimer disease (AD) need to show statistically significant benefit over placebo with respect to cognitive and functional measures, with the Clinical ...
Marwan N. Sabbagh +9 more
doaj +1 more source
Dementia with Lewy bodies [PDF]
Editor – I read with interest the ‘Acute presentation of dementia with Lewy bodies’ by Akintade and Pierres in the July edition of Clinical Medicine. [1][1] In my own practice I have seen a similar case. A diagnosis of dementia with Lewy bodies (DLB) was suspected based on clinical history,
openaire +5 more sources
Pharmacological Management of Lewy Body Dementia: A Systematic Review and Meta-Analysis. [PDF]
OBJECTIVE: The authors examined research on effects, costs, and patient and caregiver views of pharmacological management strategies for Lewy body dementia.
Cambridge, Victoria +9 more
core +2 more sources
The Alzheimer variant of Lewy body disease: A pathologically confirmed case-control study [PDF]
The objective of the study was to identify clinical features that distinguish patients with dementia with Lewy bodies (DLB), who were classified as Alzheimer's disease ( AD) patients, from patients with AD.
Busch, R. +7 more
core +1 more source
Neuroinflammation in Lewy body dementia. [PDF]
Neuroinflammation is increasingly recognized as a key factor in the pathogenesis of neurodegenerative conditions. However, it remains unclear whether it has a protective or damaging role.
O'Brien, John T +2 more
core +2 more sources
A new visual rating scale for Ioflupane imaging in Lewy body disease
Background: Dopaminergic loss on 123I-Ioflupane brain imaging is a recognised biomarker for dementia with Lewy bodies. It is usually assessed using a visual rating scale developed for Parkinson's disease, which may not be optimal for dementia with Lewy ...
Jim J. Lloyd +7 more
doaj +1 more source
Neural correlates of attention-executive dysfunction in lewy body dementia and Alzheimer's disease. [PDF]
Attentional and executive dysfunction contribute to cognitive impairment in both Lewy body dementia and Alzheimer's disease. Using functional MRI, we examined the neural correlates of three components of attention (alerting, orienting, and executive ...
Alan J. Thomas +101 more
core +1 more source
This article provides an overview of the clinical features, neuropathologic findings, diagnostic criteria, and management of dementia with Lewy bodies (DLB) and Parkinson disease dementia (PDD), together known as the Lewy body dementias.DLB and PDD are common, clinically similar syndromes that share characteristic neuropathologic changes, including ...
openaire +2 more sources
Mixed Brain Pathologies in Dementia: The BrainNet Europe Consortium Experience [PDF]
Background: Dementia results from heterogeneous diseases of the brain. Mixed disease forms are increasingly recognized. Methods: We performed a survey within brain banks of BrainNet Europe to estimate the proportion of mixed disease forms underlying ...
Al-Sarraj, Safa +15 more
core +1 more source

